RT @Stiddyo: #OP0127 A post-hoc analysis of two RCTs showed that continued methotrexate increases clinical response rate
Tweet Content
#OP0127 A post-hoc analysis of two RCTs showed that continued
methotrexate increases clinical response rates in patients randomized to
placebo therapy who were considered as having previous insufficient response
to #bDMARDs. #EULAR2021 @RheumNow https://t.co/YeEVe0uwQs
Show on Archive Page
On
Display in Search Results
On
PDQ
Off